JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Bath & Body Works (NYSE:BBWI) Stock

Bath & Body Works (NYSE:BBWI) had its price target hoisted by research analysts at JPMorgan Chase & Co. from $22.00 to $24.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 19.43% from the company’s previous close.

Several other research firms also recently commented on BBWI. Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 9th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $22.00 price objective on shares of Bath & Body Works in a research note on Monday, July 6th. Barclays decreased their target price on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 28th. UBS Group cut their price target on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. Finally, Citigroup raised Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price objective on the stock in a research note on Tuesday. Four investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $22.57.

Bath & Body Works Price Performance

NYSE BBWI traded up $1.28 during trading hours on Tuesday, reaching $20.09. 1,626,757 shares of the stock traded hands, compared to its average volume of 5,609,302. The stock has a 50 day simple moving average of $20.38 and a two-hundred day simple moving average of $20.14. Bath & Body Works has a 1 year low of $14.27 and a 1 year high of $32.32. The company has a market cap of $4.05 billion, a price-to-earnings ratio of 5.63, a price-to-earnings-growth ratio of 1.92 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, sell-side analysts forecast that Bath & Body Works will post 2.63 EPS for the current fiscal year.

Hedge Funds Weigh In On Bath & Body Works

Hedge funds have recently modified their holdings of the company. Parallel Advisors LLC raised its stake in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after acquiring an additional 567 shares during the last quarter. State of Michigan Retirement System grew its stake in shares of Bath & Body Works by 1.2% in the first quarter. State of Michigan Retirement System now owns 49,300 shares of the company’s stock worth $920,000 after purchasing an additional 600 shares during the last quarter. Meeder Asset Management Inc. grew its stake in shares of Bath & Body Works by 28.5% in the fourth quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock worth $58,000 after purchasing an additional 637 shares during the last quarter. State of Wyoming increased its holdings in Bath & Body Works by 6.2% during the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock valued at $338,000 after purchasing an additional 661 shares during the period. Finally, Vident Advisory LLC raised its position in Bath & Body Works by 2.8% during the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock valued at $756,000 after purchasing an additional 692 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.